加州资源(CRC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRC 加州资源

盘前交易 09-14 04:23:30 EDT

56.75

+0.50

+0.89%

盘前57.18

+0.43+0.76%

04:15 EDT

最高57.11	最低55.73	成交量93.56万
今开56.31	昨收56.25	日振幅2.45%
总市值50.28亿	流通市值47.42亿	总股本8,860万
成交额5,304万	换手率1.12%	流通股本8,356万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRC","market":"US","secType":"STK","nameCN":"加州资源","latestPrice":56.75,"timestamp":1789156800000,"preClose":56.25,"halted":0,"volume":935561,"hourTrading":{"tag":"盘前","latestPrice":57.18,"preClose":56.75,"latestTime":"04:15 EDT","volume":22,"amount":1260.27,"timestamp":1789373739101,"change":0.43,"changeRate":0.007577,"amplitude":0.001938},"delay":0,"changeRate":0.008888888888888889,"floatShares":83557942,"shares":88597474,"eps":-1.403794,"marketStatus":"盘前交易","change":0.5,"latestTime":"09-14 04:23:30 EDT","open":56.31,"high":57.11,"low":55.73,"amount":53036787.495703,"amplitude":0.024533,"askPrice":63.44,"askSize":100,"bidPrice":28.33,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.403794,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789392600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1415854800000,"exchange":"NYSE","adjPreClose":56.75,"dividendRate":0.028238,"preHourTrading":{"tag":"盘前","latestPrice":57.18,"preClose":56.75,"latestTime":"04:15 EDT","volume":22,"amount":1260.27,"timestamp":1789373739101,"change":0.43,"changeRate":0.007577,"amplitude":0.001938},"postHourTrading":{"tag":"盘后","latestPrice":56.75,"preClose":56.75,"latestTime":"19:30 EDT","volume":15653,"amount":888307.75,"timestamp":1789169408439,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9199467438883839,"impliedVol":0.3401,"impliedVolPercentile":0.028},"requestUrl":"/m/hq/s/CRC","defaultTab":"news","newsList":[{"id":"1153766512","title":"加州资源公司收购交易：囊括2000英里管道，日输送能力达40万桶","url":"https://stock-news.laohu8.com/highlight/detail?id=1153766512","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153766512?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:03","pubTimestamp":1786363387,"startTime":"0","endTime":"0","summary":"加州资源公司（California Resources Corporation）此次收购动作规模宏大。其资产包中，包含了一条延绵2000英里的管道网络。更值得关注的是，这条管道的日输送能力高达40万桶（即400,000 Bpd）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","LU0456854461.SGD","CRC","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143294691","title":"加州资源公司通过战略性中游收购，扩大其在加利福尼亚州的一体化能源基础设施平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1143294691","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143294691?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:01","pubTimestamp":1786363310,"startTime":"0","endTime":"0","summary":"加州资源公司正在通过一笔战略性中游收购，进一步拓展其位于加利福尼亚州的一体化能源基础设施平台。此举旨在巩固其行业地位，并强化公司在当地能源领域的布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","LU0456854461.SGD","CRC","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105176299","title":"财报前瞻｜加州资源本季度营收预计增24.44%，机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1105176299","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105176299?lang=zh_cn&edition=full","pubTime":"2026-08-03 08:27","pubTimestamp":1785716825,"startTime":"0","endTime":"0","summary":"加州资源将于2026年08月10日发布最新季度财报，市场关注油气价格与整合协同对盈利的影响。市场一致预期本季度加州资源营收约为9.77亿美元，同比增24.44%；调整后每股收益预计为1.43美元，同比增57.52%；EBIT预计为2.47亿美元，同比增73.06%。加州资源上季度实现营收9.67亿美元，同比增长6.03%；归属于母公司股东的净亏损为7.11亿美元，净利率为-73.53%，毛利率为56.67%；调整后每股收益为0.88美元，同比下降17.76%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜加州资源本季度营收预计增24.44%，机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652757144","title":"数据：BSC 链上项目 众环 CRC 遭可疑攻击，损失约 20.14 万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652757144","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652757144?lang=zh_cn&edition=full","pubTime":"2026-07-17 09:20","pubTimestamp":1784251254,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据 TenArmorAlert 监测，BSC 链上项目“众环 CRC”（CrowdRingCircle）遭可疑攻击，损失约 20.14 万美元。 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2276908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456854461.SGD","CRC","BK4213","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651610621","title":"加州资源公司：2026年第二季度含衍生品的已实现油价为每桶76.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2651610621","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651610621?lang=zh_cn&edition=full","pubTime":"2026-07-14 21:06","pubTimestamp":1784034372,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["WEEI","UGA","DUG","IXC","PEJ","OIH","DRLL","DRIP","IEO","DIG","LU0266512127.USD","OILT","BK4213","SPXT","SDOG","CRC","DBC","OILK","XES","TPOR","ERX","UDN","FTXN","PXE","BWET","USE","USOI","OILU","VDE","BK4585","VOOV","DBO","UAE","USL","WTIU","UUP","BK4570","LU0456854461.SGD","GUSH","BNO","DBE","PXJ","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134155635","title":"加州资源公司：SEC文件披露2026年第二季度商品衍生品净结算预估亏损1.9亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134155635","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134155635?lang=zh_cn&edition=full","pubTime":"2026-07-14 21:05","pubTimestamp":1784034316,"startTime":"0","endTime":"0","summary":"根据提交至美国证券交易委员会（SEC）的文件，加州资源公司（California Resources Corp）预计，在2026年第二季度，其商品衍生品净结算将产生约1.9亿美元的亏损。\n这一预估亏损反映了公司在应对商品价格波动时所面临的风险敞口。衍生品合约通常被能源公司用于对冲价格风险，但结算时可能因市场走势与预期相反而产生重大财务影响。\n文件披露的细节凸显了商品市场波动对企业财务业绩的潜在冲击。投资者在评估能源板块公司时，需密切关注此类衍生品头寸及其相关的损益波动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456854461.SGD","BK4213","CRC","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143656174","title":"Gerdes能源研究上调加州资源评级至买入，目标价提升1美元至67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143656174","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143656174?lang=zh_cn&edition=full","pubTime":"2026-06-24 13:53","pubTimestamp":1782280395,"startTime":"0","endTime":"0","summary":"Gerdes能源研究机构将加州资源的投资评级从中性上调至买入，同时将其目标股价提高了1美元，至每股67美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456854461.SGD","BK4213","CRC","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640921641","title":"核心管线数据利空 基石药业股价大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2640921641","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640921641?lang=zh_cn&edition=full","pubTime":"2026-06-03 07:00","pubTimestamp":1780441200,"startTime":"0","endTime":"0","summary":"6月1日盘前，基石药业（2616.HK）宣布核心资产CS2009（PD-1/VEGF/CTLA-4三特异性抗体）的多项关键临床进展，于美国临床肿瘤学会（ASCO）年会上通过两份壁报正式发布，涵盖一线及后线非小细胞肺癌（NSCLC）及结直肠癌（CRC）患者I/II期临床试验数据，以及晚期实体瘤患者更长随访后的成熟I期临床数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606033757998235.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606033757998235.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0456854461.SGD","BK4213","LU0266512127.USD","CRC","ORR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640438958","title":"核心管线数据利空，基石药业股价大跌超32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640438958","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640438958?lang=zh_cn&edition=full","pubTime":"2026-06-01 18:05","pubTimestamp":1780308300,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者韩利明6月1日盘前，基石药业（2616.HK）宣布核心资产CS2009（PD-1/VEGF/CTLA-4三特异性抗体）的多项关键临床进展，于美国临床肿瘤学会（ASCO）年会上通过两份壁报正式发布，涵盖一线及后线非小细胞肺癌（NSCLC）及结直肠癌（CRC）患者I/II期临床试验数据，以及晚期实体瘤患者更长随访后的成熟I期临床数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606013756146980.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606013756146980.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0266512127.USD","LU0456854461.SGD","BK4213","CRC","ORR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640981923","title":"ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640981923","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640981923?lang=zh_cn&edition=full","pubTime":"2026-06-01 08:27","pubTimestamp":1780273622,"startTime":"0","endTime":"0","summary":"格隆汇6月1日丨基石药业-B宣布，公司核心资产CS2009的多项临床关键进展，于美国临床肿瘤学会年会上通过两份壁报正式发布，涵盖CS2009在一线及后线非小细胞肺癌和结直肠癌患者中的I/II期临床试验数据，以及晚期实体瘤患者更长随访后的成熟I期临床数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260601/32265512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","CRC","02616","BK1574","LU0266512127.USD","BK4213","LU0456854461.SGD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2637879691","title":"创胜集团医药-B(06628)合作伙伴INHIBRX报告OZEKIBART的CRC最新积极数据并宣布就治疗软骨肉瘤提交美国BLA申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2637879691","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637879691?lang=zh_cn&edition=full","pubTime":"2026-05-21 06:25","pubTimestamp":1779315934,"startTime":"0","endTime":"0","summary":"智通财经APP讯，创胜集团医药-B 发布公告，其合作伙伴Inhibrx Biosciences, Inc. 近期报告了其评估ozekibart 联合FOLFIRI用于局部晚期或转移性、不可切除结直肠癌患者的1/2期研究的积极更新中期数据。除CRC适应症外，Inhibrx宣布ozekibart于软骨肉瘤方面取得一项重要监管里程碑。于2026年4月，Inhibrx已向FDA提交ozekibart用于常规软骨肉瘤的BLA，而该疾病目前尚无获批准的系统性治疗选项。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444232.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06628","159938","BK1515","CRC","LU0266512127.USD","BK4213","BK1161","BK1574","09939","LU0456854461.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180996061","title":"加州资源公司上调2026年Berry并购年度协同效应目标中值12%至9-10亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1180996061","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180996061?lang=zh_cn&edition=full","pubTime":"2026-05-06 05:21","pubTimestamp":1778016090,"startTime":"0","endTime":"0","summary":"加州资源公司宣布将其2026年Berry并购交易产生的年度协同效应目标区间中值上调12%，新目标设定为9亿至10亿美元。此次调整反映出公司对合并后运营效率提升和成本节约潜力的更乐观评估。\n该能源企业通过优化资产整合与业务流程重组，预计将实现显著的经济效益。修订后的协同目标彰显了管理层对达成战略并购价值的坚定信心，也为投资者提供了更明确的财务指引。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456854461.SGD","CRC","BK4213","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161491384","title":"财报前瞻｜加州资源本季度营收预计增8.71%，机构观点偏向看多","url":"https://stock-news.laohu8.com/highlight/detail?id=1161491384","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161491384?lang=zh_cn&edition=full","pubTime":"2026-04-28 12:08","pubTimestamp":1777349302,"startTime":"0","endTime":"0","summary":"加州资源将于2026年05月05日盘后发布新财季业绩，市场关注产量目标推进、并购协同落地与利润率修复节奏。市场一致预期本季度加州资源营收为9.37亿美元，同比增加8.71%；调整后每股收益为0.85美元，同比增加8.68%，息税前利润预计为1.30亿美元，同比小幅增长0.26%。目前一致预期尚未给出本季度毛利率、净利率或净利润的明确指引，需待公司披露。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜加州资源本季度营收预计增8.71%，机构观点偏向看多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518220378","title":"Check-Cap Ltd.盘中异动 急速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518220378?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:30","pubTimestamp":1741624250,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时30分，Check-Cap Ltd.股票出现异动，股价快速下挫5.01%。截至发稿，该股报0.762美元/股，成交量9459股，换手率0.16%，振幅2.50%。Check-Cap Ltd.股票所在的生命科学行业中，整体跌幅为0.25%。Check-Cap Ltd.公司简介：Check-Cap Ltd 是一家临床阶段的医疗诊断公司，致力于开发可摄取的成像胶囊，该胶囊利用低剂量 X 射线对结肠息肉和结直肠癌  进行检测和成像。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100305096405aaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100305096405aaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHEK","CRC","LU0266512127.USD","BK4213","LU0456854461.SGD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518275052","title":"Guardant Health, Inc.盘中异动 早盘急速下跌5.04%报37.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518275052?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:52","pubTimestamp":1741614746,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时52分，Guardant Health, Inc.股票出现异动，股价大幅跳水5.04%。Guardant Health, Inc.股票所在的生命科学行业中，整体跌幅为0.38%。Guardant Health, Inc.公司简介：Guardant Health, Inc 总部位于加利福尼亚州雷德伍德城，是液体癌症检测领域的领先者，用于临床和研究用途。此外，Guardant还提供研究开发服务，如监管批准咨询和临床试验转诊。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021522798a2a276&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021522798a2a276&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","BK4588","BK4551","LU0456854461.SGD","LU0266512127.USD","BK4535","CRC","BK4196","GH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518644773","title":"加州资源2024财年实现净利润3.76亿美元，同比减少33.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518644773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518644773?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449680,"startTime":"0","endTime":"0","summary":"3月9日，加州资源公布财报，公告显示公司2024财年净利润为3.76亿美元，同比减少33.33%；其中营业收入为29.57亿美元，同比增加5.12%，每股基本收益为4.74美元。从资产负债表来看，加州资源总负债35.97亿美元，其中短期债务15.00百万美元，资产负债比为1.99，流动比率为1.05。机构评级：截至2025年3月9日，当前有15家机构对加州资源目标价做出预测，其中目标均价为66.93美元，其中最低目标价为51.00美元，最高目标价为80.00美元。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000250abef98aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000250abef98aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517167564","title":"Nextcure, Inc.盘中异动 早盘大幅上涨5.41%报0.780美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517167564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517167564?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:04","pubTimestamp":1741277091,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时04分，Nextcure, Inc.股票出现异动，股价快速上涨5.41%。截至发稿，该股报0.780美元/股，成交量2.2204万股，换手率0.08%，振幅4.36%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000451abeb8e07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000451abeb8e07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXTC","BK4139","LU0456854461.SGD","LU0266512127.USD","BK4213","CRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517792169","title":"Guardant Health, Inc.盘中异动 大幅跳水5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517792169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517792169?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:36","pubTimestamp":1741271799,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时36分，Guardant Health, Inc.股票出现异动，股价急速下跌5.34%。Guardant Health, Inc.股票所在的生命科学行业中，整体涨幅为0.31%。Guardant Health, Inc.公司简介：Guardant Health, Inc 总部位于加利福尼亚州雷德伍德城，是液体癌症检测领域的领先者，用于临床和研究用途。此外，Guardant还提供研究开发服务，如监管批准咨询和临床试验转诊。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223639abeb793c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223639abeb793c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","GH","BK4213","BK4551","BK4535","LU0456854461.SGD","LU0266512127.USD","BK4588","BK4585","CRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517943623","title":"Nextcure, Inc.盘中异动 大幅拉升5.53%报0.780美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517943623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517943623?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:49","pubTimestamp":1741186149,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时49分，Nextcure, Inc.股票出现波动，股价急速上涨5.53%。截至发稿，该股报0.780美元/股，成交量770股，换手率0.00%，振幅0.00%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224909963ae0f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224909963ae0f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","NXTC","CRC","BK4139","LU0266512127.USD","LU0456854461.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517160479","title":"巴克莱：维持California Resources(CRC.US)评级，由持股观望调整至持股观望评级, 目标价由57.00美元调整至55.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517160479","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517160479?lang=zh_cn&edition=full","pubTime":"2025-03-05 20:44","pubTimestamp":1741178664,"startTime":"0","endTime":"0","summary":"巴克莱：维持California Resources(CRC.US)评级，由持股观望调整至持股观望评级, 目标价由57.00美元调整至55.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05204448546784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CRC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crc.com","stockEarnings":[{"period":"1week","weight":0.0467},{"period":"1month","weight":0.0613},{"period":"3month","weight":-0.0317},{"period":"6month","weight":-0.0768},{"period":"1year","weight":0.0826},{"period":"ytd","weight":0.2693}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"California Resources Corporation于2014年4月23日在特拉华州注册成立。该公司从Occidental公司分离出来之后是一家独立的石油和天然气勘探和生产公司，专注于高增长，高回报在加利福尼亚州的常规和非常规资产。加利福尼亚州是世界上最丰富的石油和天然气生产地区之一，是全美国第三大石油生产州。该公司在加利福尼亚州的总经营的基础上是最大的生产商。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.004081},{"month":2,"riseRate":0.5,"avgChangeRate":0.032338},{"month":3,"riseRate":0.5,"avgChangeRate":0.021791},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.055622},{"month":5,"riseRate":0.5,"avgChangeRate":0.046881},{"month":6,"riseRate":0.666667,"avgChangeRate":0.029443},{"month":7,"riseRate":0.5,"avgChangeRate":0.048765},{"month":8,"riseRate":1,"avgChangeRate":0.072837},{"month":9,"riseRate":0.666667,"avgChangeRate":0.01844},{"month":10,"riseRate":0.4,"avgChangeRate":0.023069},{"month":11,"riseRate":0.666667,"avgChangeRate":0.101056},{"month":12,"riseRate":0.5,"avgChangeRate":0.002283}],"exchange":"NYSE","name":"加州资源","nameEN":"California Resources"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"加州资源(CRC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供加州资源(CRC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"加州资源,CRC,加州资源股票,加州资源股票老虎,加州资源股票老虎国际,加州资源行情,加州资源股票行情,加州资源股价,加州资源股市,加州资源股票价格,加州资源股票交易,加州资源股票购买,加州资源股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"加州资源(CRC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供加州资源(CRC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}